Ensifentrine (Ohtuvayre) for COPD: 2024 FDA Approval, ENHANCE Trials, and What You Need to Know
Apr 29, 2025•Channel
AI Analysis
Data from YouTube Data API v3•Updated Just now
Video Overview
Video Details
PublishedApr 29, 2025
Duration13:04
Video IDk50YS5hyoDw
Languageen
CategoryEducation
PrivacyPublic
Made for KidsNo
Video TypeRegular Video
Performance Metrics
Views6.3K
Likes391
Comments49
Engagement Rate7.02%
Likes per 100 views6.24
Comments per 1K views7.82
Video Tags
#inhalers (asthma & copd treatment)#asthma treatment#copd treatment#respiratory pharmacology#asthma medications#copd#bronchodilators#asthma#bronchodilators pharmacology#asthma pharmacology#asthma medicine#inhalers#bronchial asthma pharmacology#inhaler#asthma inhaler#asthma medication#salbutamol mechanism of action#respiratory drugs pharmacology#ipratropium bromide#asthma drugs
Description
Roger Seheult, MD of MedCram explains a new FDA approved medication for COPD and the ENHANCE trials. See all Dr. Seheult's videos at: https://www.medcram.com/
(This video was recorded on April 28th, 2025)
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com/
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
LINKS / REFERENCES:
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (American journal of respiratory and critical care medicine) | https://pubmed.ncbi.nlm.nih.gov/37364283/
Ensifentrine, a Novel Dual Phosphodiesterase (PDE) 3 and 4 Inhibitor, Significantly Reduces Annualized Exacerbations and Delays the Time to First Exacerbation in COPD: Pooled Sub-Group Analyses of Enhance-1 and Enhance-2 Phase 3 Trials (American Journal of Respiratory and Critical Care Medicine) | https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A5008
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
https://www.youtube.com/user/MEDCRAMvideos?Exposure to a more unhealthy diet impacts sleep microstructure during normal sleep and recovery sleep: A randomized trial=1
Get notified of new videos by hitting the bell icon
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at [email protected] if you are interested.
MEDIA CONTACT:
Media Contact: [email protected]
Media contact info: https://www.medcram.com/pages/media-contact?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Insights+Into+Cirrhotic+Bleeding+of+the+Liver%2C+and+How+to+Stop+It&utm_content=CaBnPmyY5kE
Video Produced by Kyle Allred
FOLLOW US ON SOCIAL MEDIA:
https://www.facebook.com/MedCram
https://twitter.com/MedCramVideos
https://www.instagram.com/medcram
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
#COPD #FDA #Ensifentrine